GENE ONLINE|News &
Opinion
Blog

2025-11-27|

Study Reveals GNSS Signal Disruption in Sports Stadiums Due to Structural Interference

by GOAI
Share To

A recent study examines the quantitative impact of Global Navigation Satellite Systems (GNSS) signal disruption in sports stadiums, highlighting challenges faced in enclosed environments. GNSS technology is widely used in modern sports for applications such as tracking athlete performance and enhancing spectator experiences. However, researchers have identified significant disruptions to these signals within stadiums, which can interfere with the functionality of GNSS-dependent systems.

The study focuses on understanding how structural elements of stadiums contribute to signal interference. Enclosed spaces, dense construction materials, and complex architectural designs are reported to obstruct satellite signals, leading to reduced accuracy and reliability. This issue affects various technologies reliant on GNSS data, including real-time player tracking systems and navigation tools used by spectators. The findings aim to provide insights into mitigating these disruptions and improving GNSS functionality in similar environments.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 27, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top